Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Status:
Completed
Trial end date:
2004-04-27
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of eflornithine may be an effective way to
prevent the recurrence of or further development of cervical cancer.
PURPOSE: Randomized phase II trial to determine the effectiveness of eflornithine in
preventing cervical cancer in patients who have cervical intraepithelial neoplasia.